Chemotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Chemotherapy, including details on cancer treatment, side effects, drugs.

Volume 8 (2011), Issue 3 (March)

1. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
   J Acquir Immune Defic Syndr, 56(4): 356-64. [Abstract] [Full-text]
2. Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat.
   Toxicol Appl Pharmacol, 251(3): 181-90. [Abstract] [Full-text]
3. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
   J Acquir Immune Defic Syndr, 56(4): 356-64. [Abstract] [Full-text]
4. Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat.
   Toxicol Appl Pharmacol, 251(3): 181-90. [Abstract] [Full-text]
5. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire.
   J Acquir Immune Defic Syndr, 56(4): 356-64. [Abstract] [Full-text]
6. All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer.
   Cancer Treat Rev, 37(3): 221-33. [Abstract] [Full-text]
7. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation.
   Biomaterials, 32(13): 3481-6. [Abstract] [Full-text]
8. Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery.
   Biomaterials, 32(13): 3487-98. [Abstract] [Full-text]
9. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.
   Biomaterials, 32(13): 3447-58. [Abstract] [Full-text]
10. Hierarchical nanoengineered surfaces for enhanced cytoadhesion and drug delivery.
    Biomaterials, 32(13): 3499-506. [Abstract] [Full-text]
11. All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer.
    Cancer Treat Rev, 37(3): 221-33. [Abstract] [Full-text]
12. Acute promyelocytic leukemia following chemotherapy for EBV-associated hemophagocytic lymphohistiocytosis.
    Pediatr Blood Cancer, 56(5): 850-2. [Abstract] [Full-text]
13. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal tumour study group.
    Pediatr Blood Cancer, 56(5): 733-7. [Abstract] [Full-text]
14. Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96.
    Pediatr Blood Cancer, 56(5): 718-24. [Abstract] [Full-text]
15. An aggressive systemic juvenile xanthogranuloma clonally related to a preceding T-cell acute lymphoblastic leukemia.
    Pediatr Blood Cancer, 56(5): 859-62. [Abstract] [Full-text]
16. Contending mediated risk messages: a grounded theory of the physician-patient discussion of a prescription medication's changing risk.
    Patient Educ Couns, 83(1): 14-21. [Abstract] [Full-text]
17. Information needs about medication according to patients discharged from a general hospital.
    Patient Educ Couns, 83(1): 22-8. [Abstract] [Full-text]
18. Contending mediated risk messages: a grounded theory of the physician-patient discussion of a prescription medication's changing risk.
    Patient Educ Couns, 83(1): 14-21. [Abstract] [Full-text]
19. Information needs about medication according to patients discharged from a general hospital.
    Patient Educ Couns, 83(1): 22-8. [Abstract] [Full-text]
20. Protein spherulites for sustained release of interferon: preparation, characterization and in vivo evaluation.
    J Pharm Sci, 100(5): 1913-22. [Abstract] [Full-text]
21. Fatty acid and water-soluble polymer-based controlled release drug delivery system.
    J Pharm Sci, 100(5): 1900-12. [Abstract] [Full-text]
22. Development, characterization, and in vitro and in vivo evaluation of benzocaine- and lidocaine-loaded nanostructrured lipid carriers.
    J Pharm Sci, 100(5): 1892-9. [Abstract] [Full-text]
23. Polyamidoamine dendrimers can improve the pulmonary absorption of insulin and calcitonin in rats.
    J Pharm Sci, 100(5): 1866-78. [Abstract] [Full-text]
24. In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model.
    J Pharm Sci, 100(5): 1819-32. [Abstract] [Full-text]
25. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
    J Pharm Sci, 100(5): 1805-18. [Abstract] [Full-text]
26. Encapsulation of valproate-loaded hydrogel nanoparticles in intact human erythrocytes: a novel nano-cell composite for drug delivery.
    J Pharm Sci, 100(5): 1702-11. [Abstract] [Full-text]
27. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
    J Pharm Sci, 100(5): 1760-72. [Abstract] [Full-text]
28. Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD.
    Psychoneuroendocrinology, 36(4): 502-13. [Abstract] [Full-text]
29. Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly(2-oxazoline)s nanoformulation.
    Biomaterials, 32(14): 3654-65. [Abstract] [Full-text]
30. LL-37 as a therapeutic target for late stage prostate cancer.
    Prostate, 71(6): 659-70. [Abstract] [Full-text]
31. Interactions of biomacromolecules with reverse hexagonal liquid crystals: drug delivery and crystallization applications.
    J Colloid Interface Sci, 356(2): 375-86. [Abstract] [Full-text]
32. The application of novel spindle-like polypyrrole hollow nanocapsules containing Pt nanoparticles in electrocatalysis oxidation of nicotinamide adenine dinucleotide (NADH).
    J Colloid Interface Sci, 356(2): 757-62. [Abstract] [Full-text]
33. Multifunctional NO-delivery vessel derived from aminopropyl-modified mesoporous zeolites.
    J Colloid Interface Sci, 356(2): 526-35. [Abstract] [Full-text]
34. Potent antioxidant dendrimers lacking pro-oxidant activity.
    Free Radic Biol Med, 50(8): 918-25. [Abstract] [Full-text]
35. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    JAMA, 305(10): 1008-17. [Abstract] [Full-text]
36. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    JAMA, 305(10): 1008-17. [Abstract] [Full-text]
37. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    JAMA, 305(10): 1008-17. [Abstract] [Full-text]
38. Polypharmacy and patterns in drug prescribing at a primary healthcare centre in the Riyadh region of Saudi Arabia.
    Int J Pharm Pract, 19(2): 123-8. [Abstract] [Full-text]
39. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
    Int J Cancer, 128(9): 2050-62. [Abstract] [Full-text]
40. Polypharmacy and patterns in drug prescribing at a primary healthcare centre in the Riyadh region of Saudi Arabia.
    Int J Pharm Pract, 19(2): 123-8. [Abstract] [Full-text]
41. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
    Cancer Lett, 304(1): 33-40. [Abstract] [Full-text]
42. Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.
    Cancer Lett, 304(1): 21-32. [Abstract] [Full-text]
43. Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.
    Int J Cancer, 128(9): 2050-62. [Abstract] [Full-text]
44. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
    Cancer Lett, 304(1): 33-40. [Abstract] [Full-text]
45. Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo.
    Cancer Lett, 304(1): 21-32. [Abstract] [Full-text]
46. Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
    N Engl J Med, 364(10): 947-55. [Abstract] [Full-text]
47. Treatment of non-small-cell lung cancer with erlotinib or gefitinib.
    N Engl J Med, 364(10): 947-55. [Abstract] [Full-text]
48. Partially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.
    Nanotechnology, 22(15): 155605. [Abstract] [Full-text]
49. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
    Br J Haematol, 153(1): 58-65. [Abstract] [Full-text]
50. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
    Eur J Surg Oncol, 37(4): 312-8. [Abstract] [Full-text]
51. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
    Eur J Surg Oncol, 37(4): 336-43. [Abstract] [Full-text]
52. Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapy.
    Eur J Surg Oncol, 37(4): 364-9. [Abstract] [Full-text]
53. Bioconjugated PLGA-4-arm-PEG branched polymeric nanoparticles as novel tumor targeting carriers.
    Nanotechnology, 22(16): 165101. [Abstract] [Full-text]
54. Collagen containing microcapsules: smart containers for disease controlled therapy.
    J Colloid Interface Sci, 357(1): 56-62. [Abstract] [Full-text]
55. Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.
    J Infect Dis, 203(7): 992-1001. [Abstract] [Full-text]
56. Resuscitation in massive obstetric haemorrhage using an intraosseous needle.
    Anaesthesia, 66(4): 306-10. [Abstract] [Full-text]
57. Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.
    Ultrastruct Pathol, 35(3): 119-23. [Abstract] [Full-text]
58. Chemotherapy wafers for high grade glioma.
    Cochrane Database Syst Rev, 3: CD007294. [Abstract] [Full-text]
59. Colloid solutions for fluid resuscitation.
    Cochrane Database Syst Rev, 3: CD001319. [Abstract] [Full-text]
60. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
    Cochrane Database Syst Rev, 3: CD000567. [Abstract] [Full-text]
61. Chemotherapy wafers for high grade glioma.
    Cochrane Database Syst Rev, 3: CD007294. [Abstract] [Full-text]
62. Colloid solutions for fluid resuscitation.
    Cochrane Database Syst Rev, 3: CD001319. [Abstract] [Full-text]
63. Colloids versus crystalloids for fluid resuscitation in critically ill patients.
    Cochrane Database Syst Rev, 3: CD000567. [Abstract] [Full-text]
64. The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects.
    Vet J, 188(1): 34-8. [Abstract] [Full-text]
65. Is radiotherapy an option for early breast cancers with complete clinical response after neoadjuvant chemotherapy?
    Int J Radiat Oncol Biol Phys, 79(5): 1452-9. [Abstract] [Full-text]
66. Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 79(5): 1395-401. [Abstract] [Full-text]
67. Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.
    Int J Radiat Oncol Biol Phys, 79(5): 1428-35. [Abstract] [Full-text]
68. Primary bovine synoviocyte cultures: a useful tool for in vitro drug testing?
    Vet J, 188(1): 58-63. [Abstract] [Full-text]
69. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
    Cancer, 117(7): 1498-505. [Abstract] [Full-text]
70. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study.
    Cancer, 117(7): 1422-8. [Abstract] [Full-text]
71. A prospective study of prophylactic long-acting octreotide in high-risk patients undergoing pancreaticoduodenectomy.
    Am J Surg, 201(4): 481-5. [Abstract] [Full-text]
72. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy.
    Am J Ophthalmol, 151(4): 594-603.e1. [Abstract] [Full-text]
73. Outcomes of birdshot chorioretinopathy treated with an intravitreal sustained-release fluocinolone acetonide-containing device.
    Am J Ophthalmol, 151(4): 630-6. [Abstract] [Full-text]
74. Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis.
    Am J Ophthalmol, 151(4): 697-702.e2. [Abstract] [Full-text]
75. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation.
    Fertil Steril, 95(5): 1787.e1-4. [Abstract] [Full-text]
76. Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women.
    Fertil Steril, 95(5): 1790-3. [Abstract] [Full-text]
77. Weight gain in breast cancer survivors: prevalence, pattern and health consequences.
    Obes Rev, 12(4): 282-94. [Abstract] [Full-text]
78. A computerized system for reporting medication events in psychiatry: the first two years of operation.
    J Psychiatr Ment Health Nurs, 18(4): 308-15. [Abstract] [Full-text]
79. Nurse prescribing in specialist mental health (part 2): the views and experiences of psychiatrists and health professionals.
    J Psychiatr Ment Health Nurs, 18(4): 281-7. [Abstract] [Full-text]
80. Polycarbonate microspheres containing mitomycin C and magnetic powders as potential hepatic carcinoma therapeutics.
    Colloids Surf B Biointerfaces, 84(2): 550-5. [Abstract] [Full-text]
81. In vivo evidence for a significant role of folylpolyglutamate synthase in combined chemotherapy with oral fluoropyrimidine, UFT or S-1, and leucovorin.
    Oncol Rep, 25(5): 1407-12. [Abstract] [Full-text]
82. Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression.
    Cancer Lett, 304(2): 90-6. [Abstract] [Full-text]
83. Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.
    Colloids Surf B Biointerfaces, 84(2): 498-507. [Abstract] [Full-text]
84. Structural characterization of novel phospholipid lipid nanoparticles for controlled drug delivery.
    Colloids Surf B Biointerfaces, 84(2): 406-12. [Abstract] [Full-text]
85. Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells.
    Int J Oncol, 38(5): 1237-43. [Abstract] [Full-text]
86. 3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier.
    Colloids Surf B Biointerfaces, 84(2): 585-90. [Abstract] [Full-text]
87. Dual temperature/pH-sensitive drug delivery of poly(N-isopropylacrylamide-co-acrylic acid) nanogels conjugated with doxorubicin for potential application in tumor hyperthermia therapy.
    Colloids Surf B Biointerfaces, 84(2): 447-53. [Abstract] [Full-text]
88. Chitosan microspheres as a delivery system for nasal insufflation.
    Colloids Surf B Biointerfaces, 84(2): 384-9. [Abstract] [Full-text]
89. Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.
    Colloids Surf B Biointerfaces, 84(2): 329-37. [Abstract] [Full-text]
90. Evaluation of chronic alcohol self-administration by a 3-bottle choice paradigm in adult male rats. Effects on behavioural reactivity, spatial learning and reference memory.
    Behav Brain Res, 219(2): 213-20. [Abstract] [Full-text]
91. Oral candidiasis mimicking tongue cancer.
    Auris Nasus Larynx, 38(3): 418-20. [Abstract] [Full-text]
92. Thymidylate synthase expression as a predictor of clinical response to 5-fluorouracil-based chemoradiotherapy in patients with maxillary sinus squamous cell carcinoma.
    Auris Nasus Larynx, 38(3): 387-91. [Abstract] [Full-text]
93. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Nanotechnology, 22(18): 185601. [Abstract] [Full-text]
94. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
    Science, 331(6024): 1612-6. [Abstract] [Full-text]
95. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.
    Science, 331(6024): 1612-6. [Abstract] [Full-text]
96. Oncolytic vesicular stomatitis virus administered by isolated limb perfusion suppresses osteosarcoma growth.
    J Orthop Res, 29(5): 795-800. [Abstract] [Full-text]
97. On-demand drug delivery from self-assembled nanofibrous gels: a new approach for treatment of proteolytic disease.
    J Biomed Mater Res A, 97(2): 103-10. [Abstract] [Full-text]
98. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents.
    J Biomed Mater Res A, 97(2): 201-11. [Abstract] [Full-text]
99. The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors.
    Biomaterials, 32(15): 3832-44. [Abstract] [Full-text]
100. Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel.
     Biomaterials, 32(15): 3862-74. [Abstract] [Full-text]
101. Development of chitosan-vancomycin antimicrobial coatings on titanium implants.
     J Biomed Mater Res A, 97(2): 167-76. [Abstract] [Full-text]
102. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
     Biochem Pharmacol, 81(8): 976-84. [Abstract] [Full-text]
103. Effective functionalization of multiwalled carbon nanotube with amphiphilic poly(propyleneimine) dendrimer carrying silver nanoparticles for better dispersability and antimicrobial activity.
     J Colloid Interface Sci, 357(2): 354-65. [Abstract] [Full-text]
104. Electrochemical detection of thrombin based on aptamer and ferrocenylhexanethiol loaded silica nanocapsules.
     Biosens Bioelectron, 26(8): 3536-41. [Abstract] [Full-text]
105. Tumor-homing photosensitizer-conjugated glycol chitosan nanoparticles for synchronous photodynamic imaging and therapy based on cellular on/off system.
     Biomaterials, 32(16): 4021-9. [Abstract] [Full-text]
106. Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier.
     J Colloid Interface Sci, 357(2): 280-5. [Abstract] [Full-text]
107. In silico and in vitro validation of serine hydroxymethyltransferase as a chemotherapeutic target of the antifolate drug pemetrexed.
     Eur J Med Chem, 46(5): 1616-21. [Abstract] [Full-text]
108. Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose.
     Eur J Pharm Biopharm, 78(1): 97-106. [Abstract] [Full-text]
109. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation.
     Eur J Pharm Biopharm, 78(1): 90-6. [Abstract] [Full-text]
110. Colloidal polyelectrolyte complexes of chitosan and dextran sulfate towards versatile nanocarriers of bioactive molecules.
     Eur J Pharm Biopharm, 78(1): 10-8. [Abstract] [Full-text]
111. pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization.
     Chem Commun (Camb), 47(15): 4493-5. [Abstract] [Full-text]
112. Self-assembled nanospheres as a novel delivery system for taxol: a molecular hydrogel with nanosphere morphology.
     Chem Commun (Camb), 47(15): 4439-41. [Abstract] [Full-text]
113. Controllable exploding microcapsules as drug carriers.
     Chem Commun (Camb), 47(15): 4457-9. [Abstract] [Full-text]
114. Acyclovir skin depot characterization following in vivo iontophoretic delivery.
     Skin Res Technol, 17(2): 234-44. [Abstract] [Full-text]
115. Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates.
     Drug Deliv, 18(4): 246-54. [Abstract] [Full-text]
116. Gastroretentive drug delivery system of acyclovir-loaded alginate mucoadhesive microspheres: formulation and evaluation.
     Drug Deliv, 18(4): 255-64. [Abstract] [Full-text]
117. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
     Drug Deliv, 18(4): 227-35. [Abstract] [Full-text]
118. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
     N Engl J Med, 364(13): 1230-42. [Abstract] [Full-text]
119. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
     N Engl J Med, 364(13): 1230-42. [Abstract] [Full-text]
120. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
     N Engl J Med, 364(13): 1230-42. [Abstract] [Full-text]
121. Predictive power of long-range corrected functionals on the spectroscopic properties of tetrapyrrole derivatives for photodynamic therapy.
     Phys Chem Chem Phys, 13(15): 7207-17. [Abstract] [Full-text]
122. Implementation of ESC-STEMI guidelines into clinical practice: an analysis of the Slovak Registry of Acute Coronary Syndromes (SLOVAKS).
     J Cardiovasc Med (Hagerstown), 12(5): 353-5. [Abstract] [Full-text]
123. Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC).
     Int J Cancer, 128(11): 2695-708. [Abstract] [Full-text]

© 2004-2012 Chemotherapy Research Today. All Rights Reserved.